AVAGLIANO MARK (Chief Business Officer) received a stock award from G1 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/18/2024ACC: 0000950170-24-107795
Officer· Chief Business Officer
Since Jul 2019
-372.55K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
20.60K acquired · 393.14K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+20.60K
Price / share
—
Trade value
—
% of position
8.5%
9/18/2024
242.04K→262.64K
Common Stock
Direct
Shares
−236.61K
Price / share
—
Trade value
—
% of position
90.1%
9/18/2024
262.64K→26.04K
Common Stock
Direct
Shares
−26.04K
Price / share
—
Trade value
—
% of position
New position
9/18/2024
26.04K→0.00
Total
Net shares
−242.04K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/18/2024 | A · Award | +20.60K | — | — | 8.5% | 242.04K | 262.64K |
| Common Stock Direct | 9/18/2024 | D · Disposition | −236.61K | — | — | 90.1% | 262.64K | 26.04K |
| Common Stock Direct | 9/18/2024 | U · U | −26.04K | — | — | New position | 26.04K | 0.00 |
| Total | −242.04K | $0.00 | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
89.40K shares
Shares
−89.40K
Strike price
2.97
Held after
0.00
Exercisable
—
9/18/2024
Stock Option (right to buy)
Direct
Converts to
Common Stock
41.10K shares
Shares
−41.10K
Strike price
5.73
Held after
0.00
Exercisable
—
9/18/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock89.40K shares | 9/18/2024 | D · Disposition | −89.40K | 2.97 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock41.10K shares | 9/18/2024 | D · Disposition | −41.10K | 5.73 | — | 0.00 |